causal

Trial-to-practice diffusion overstates real-world benefit

A randomized trial can show huge benefit for a carefully selected group of complication-free patients treated by the best doctors at the best centers; physicians read this in journals like NEJM or JAMA, conclude the treatment works, and the technology diffuses unevenly and widely—yet the actual benefit for the marginal patient outside those ideal conditions may be far smaller.

causalpending

Speaker

Jonathan Skinner

Evidence Quote

“you start wondering, 'Hmmm. How much benefit are we really getting for that marginal patient?'”

Source

Jonathan Skinner on Health Care Costs, Technology, and Rising Mortality— EconTalk
Created: 6/13/2026, 12:21:47 AM

Your notes

Loading notes...